)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Gabather
Gabather (GABA) investor relations material
Gabather Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary29 May, 2026
Executive summary
Focus during Q1 2026 was on operational execution, advancing GT-002 towards clinical validation and strengthening financial position through a directed share issue.
Initiation of the first patient study (TOTEMS) with GT-002 in schizophrenia spectrum, marking a key milestone from preclinical to clinical phase.
Strategic expansion with a new patent application for non-sedative sleep treatment, targeting a large and growing global market.
Financial highlights
Net revenue was 0 tkr, unchanged year-over-year.
Operating loss widened to -1,052 tkr from -303 tkr year-over-year.
Net loss after tax was -1,067 tkr compared to -336 tkr in Q1 2025.
Cash flow for the period was 2,894 tkr, down from 4,127 tkr in Q1 2025.
Cash and cash equivalents at period end were 6,037 tkr, up from 3,143 tkr at year-end 2025.
Outlook and guidance
Liquidity after the March 2026 share issue is deemed sufficient to finance operations for the next twelve months.
Ongoing evaluation of new financing options and further cost savings to strengthen capital structure.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Gabather
- Gabather launches a SEK 21.4 million rights issue and advances its neuropsychiatric drug pipeline.GABA
Investor Update24 Apr 2026 - Operating loss narrowed, but further financing is needed to sustain operations into 2026.GABAQ4 202527 Feb 2026
- SEK 21.4 million rights issue supports Phase II GT-002 trial and March 2025 investor events.GABAInvestor Update27 Dec 2025
- Operating losses persist amid zero revenue and delayed clinical milestones; liquidity remains tight.GABAQ3 202527 Nov 2025
- GT002 advances in phase 2 trials with patent progress and partnership talks targeting 2025 milestones.GABAInvestor Update24 Nov 2025
- GT002 enters phase II for schizophrenia cognition; TO 7 warrants could raise 5.3 MSEK.GABAInvestor Update20 Nov 2025
- Operating loss narrowed, but liquidity remains a concern as clinical progress continues.GABAQ2 202528 Aug 2025
- Operating loss reduced, but negative equity and urgent financing needs persist.GABAQ3 202413 Jun 2025
- Losses widened and liquidity remains strained as Gabather advances GT-002 clinical trials.GABAQ2 202413 Jun 2025
Next Gabather earnings date
Q2 202631 Aug, 2026
Gabather
Next Gabather earnings date
Q2 202631 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage